NICXClinical Trials•globenewswire•August 21, 2025 at 05:30 AM

Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients

Sentiment:Positive (70)

Attachment

Read the full article from the original source for complete details and context.

Article published on August 21, 2025 by globenewswire